Monday , October 23 2017
Home / Letter From The Editor / Special Edition, SGLT2 Inhibitors, April 2014

Special Edition, SGLT2 Inhibitors, April 2014

The role of the kidneys are becoming very well known in the Ominous Octet of Diabetes. The SGLT2 receptor on the kidneys is a new target for novel treatments of diabetes. This month we have a set of very well done slides from the Worldwide Initiative for Diabetes Education that bring forth the reasons for using drugs that inhibit the reabsorption of glucose. These slides will take all the information you have been getting over the past year or so and make it easy to understand why this class of drugs is so important.